Ifp Advisors, Inc Amneal Pharmaceuticals, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 694 shares of AMRX stock, worth $7,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
694
Previous 0
Infinity%
Holding current value
$7,890
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AMRX
# of Institutions
257Shares Held
147MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA18MShares$204 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$140 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$133 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$128 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$64 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.72B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...